L-DOPA: From a biologically inactive amino acid to a successful therapeutic agent

@article{Hornykiewicz2002LDOPAFA,
  title={L-DOPA: From a biologically inactive amino acid to a successful therapeutic agent
},
  author={O. Hornykiewicz},
  journal={Amino Acids},
  year={2002},
  volume={23},
  pages={65-70}
}
Summary. The article traces the development of research on the naturally occurring amino acid L-3,4-dihydroxyphenylalanine (L-dopa), from the first synthesis of its D,L racemate in 1911, and the isolation of its L-isomer from seedling of Vicia faba beans to the amino acid's successful application, from 1961 onward, as the most efficacious drug treatment of Parkinson's disease (PD). Upon its isolation from legumes in 1913, L-dopa was declared to be biologically inactive. However, two early… Expand
In vitro Metabolic Studies of Dopamine Synthesis and the Toxicity of L-DOPA in Human Cells
In vitro Metabolic Studies of Dopamine Synthesis and the Toxicity of L-DOPA in Human Cells by Sylvie DELCAMBRE This work is divided in two parts. In the first, I investigated the effects ofExpand
Contribution of L-3,4-dihydroxyphenylalanine metabolism to the inhibition of gluconeogenesis in rabbit kidney-cortex tubules.
TLDR
The data indicate that a rapid intracellular degradation of L-3,4-dihydroxyphenylalanine and tyramine is accompanied by 25-40% decrease in glucose production from pyruvate, alanine + glycerol + octanoate and dihydroxyacetone due to augmented generation of hydrogen peroxide via monoamine oxidase B, resulting in a decline of glutathione redox state by 40%. Expand
Enzymatic assay for perfluoro-tagged metabolites of l-DOPA using crude lysate from E. coli transformed with pKKAADCII
TLDR
The enzymatic assay described here provides an efficient and cost-effective tool for screening new compounds for use in the fluorine imaging of neural pathways and is likely to follow the biosynthesis path for dopamine in vivo and are potentially useful in magnetic resonance studies. Expand
Design, Synthesis, and Biological Evaluation of Phenol Bioisosteric Analogues of 3-Hydroxymorphinan
TLDR
The in vitro study showed that imidazolone-morphinan was non-toxic to microglia, indicating its high safety, and compound 8 was nominated as a candidate for further clinical development. Expand
A brief history of levodopa
This article highlights some landmarks in the history of levodopa, beginning with its isolation in 1910–13 from seedlings of Vicia faba to the demonstration, in 1961, of its “miraculous” effect inExpand
The Role of Coffee in the Therapy of Parkinson's Disease
TLDR
Understanding the metabolic interactions between coffee, L-DOPA, and G-CSF may shed light on new therapeutic treatments to treat PD. Expand
L-DOPA-induced signaling pathways and neuroepigenetic mechanisms in experimental Parkinsonism and dyskinesia
In patients with Parkinson’s disease (PD), the restoration of depleted striatal dopamine by chronic administration of its precursor, L-DOPA, results in the emergence of debilitating involuntaryExpand
A novel and efficient synthesis of DOPA and DOPA peptides by oxidation of tyrosine residues with IBX
An efficient route to 3,4-dihydroxylphenylalanine (DOPA) and DOPA peptides was described by oxidation of l-tyrosine and l-tyrosine derivatives with 2-iodoxybenzoic acid (IBX). DOPA was obtained afterExpand
Levodopa in Parkinson’s Disease: Current Status and Future Developments
TLDR
New LD formulations, oral compounds as well as routes have been tested in the last years, with two main targets: achieve continuous dopaminergic stimulation and find an instant deliver route for LD. Expand
Biocatalytic formation of synthetic melanin: the role of vanadium haloperoxidases, L-DOPA and iodide.
TLDR
The biosynthetic melanin produced through the combination V-HPO/I/H(2)O(2), was characterized by several spectroscopic techniques (UV-vis and FT-IR) as well as XRD, and Scanning electron microscopy (SEM) imaging showed different morphologies when compared with commercial available melanin. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 60 REFERENCES
Neurotransmitter-like actions of L-DOPA.
TLDR
L-3,4-dihydroxyphenylalani is a precursor for transmitter dopamine as well as an endogenous potentiator of presynaptic P-adrenoceptors to facilitate the dopamine release and for postsynaptic D, receptors. Expand
Dual effects of l-3,4-dihydroxyphenylalanine on aromatic l-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent
TLDR
It is proposed that L-DOPA is capable of directly stimulating dopamine D2 and possibly non-dopamine receptors, thereby inhibiting dopamine efflux presynaptically and promoting motor activation postsynaptically. Expand
Is l-dopa an endogenous neurotransmitter?
Abstract Since the 1960s, l-3,4-dihydroxyphenylalanine (l-dopa), a precursor of dopamine, has been thought to occur in the cytoplasm of catecholaminergic neurones. l-Dopa is traditionally believed toExpand
The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
TLDR
It was concluded that L-dopa's principal therapeutic effects in Parkinson's disease are consistent with its transformation to DA in the striatum. Expand
Aromatic amino acids and modification of parkinsonism.
TLDR
The interrelations between melanogenesis and extrapyramidal disease might be of fundamental importance and it was noted that chronic Parkinson's disease has a common precursor in the synthesis of both melanin and catecholamines. Expand
Chemical structure and sympathomimetic action of amines
TLDR
The elucidation of the structure of the active principle of the stupra-renal medulla by the work of Abell and its synthesis by Stolz 7 and by Dakin8 led to the physiological investigation of substances nearly related to it in chemical structure. Expand
Über das Vorkommen von Katecholaminen und von 3,4-Dihydroxyphenylalanin (Dopa) im Auge
  • H. Bernheimer
  • Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
  • 2004
Summary1. The occurrence and distribution of catecholamines in the ocular tissue of the calf has been investigated by a fluorimetric method.2. In the lens, in the vitreous humour and in the retinaExpand
Concentration and Distribution of “Encephalin” in the Brain of Humans, and Animals
  • W. Raab, W. Gigee
  • Chemistry, Medicine
  • Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine
  • 1951
TLDR
Colorimetrie assay of a large number of human and animal brains for “encephalin” revealed a rather uniform pattern of intracerebral distribution in various species, which suggests either a selective absorption of this substance by the brain or its conversion into encephalin. Expand
Enzymatic decarboxylation of isomers and derivatives of dihydroxyphenylalanine.
TLDR
The quantitative data reveal that interaction between substituents on the benzene ring of the substrates, as well as the position of the groups, affects the rate of decarboxylation. Expand
RENAL HYPERTENSION PRODUCED BY AN AMINO ACID
TLDR
Evidence is presented suggesting that the rise in blood pressure following the injection of dopa is caused by its conversion into hydroxytyramine, a pressor amine. Expand
...
1
2
3
4
5
...